Stem Cell and Exosome Therapy in Pulmonary Hypertension
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oh, Seyeon | - |
dc.contributor.author | Jung, Ji-Hye | - |
dc.contributor.author | Ahn, Kyung-Jin | - |
dc.contributor.author | Jang, Albert Youngwoo | - |
dc.contributor.author | Byun, Kyunghee | - |
dc.contributor.author | Yang, Phillip C. | - |
dc.contributor.author | Chung, Wook-Jin | - |
dc.date.accessioned | 2022-02-28T06:40:45Z | - |
dc.date.available | 2022-02-28T06:40:45Z | - |
dc.date.created | 2022-02-05 | - |
dc.date.issued | 2022-02 | - |
dc.identifier.issn | 1738-5520 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/83584 | - |
dc.description.abstract | Pulmonary hypertension is a rare and progressive illness with a devastating prognosis. Promising research efforts have advanced the understanding and recognition of the pathobiology of pulmonary hypertension. Despite remarkable achievements in terms of improving the survival rate, reducing disease progression, and enhancing quality of life, pulmonary arterial hypertension (PAH) is not completely curable. Therefore, an effective treatment strategy is still needed. Recently, many studies of the underlying molecular mechanisms and technological developments have led to new approaches and paradigms for PAH treatment. Management based on stem cells and related paracrine effects, epigenetic drugs and gene therapies has yielded prospective results for PAH treatment in preclinical research. Further trials are ongoing to optimize these important insights into clinical circumstances. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한심장학회 | - |
dc.relation.isPartOf | Korean Circulation Journal | - |
dc.title | Stem Cell and Exosome Therapy in Pulmonary Hypertension | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000753368000002 | - |
dc.identifier.doi | 10.4070/kcj.2021.0191 | - |
dc.identifier.bibliographicCitation | Korean Circulation Journal, v.52, no.2, pp.110 - 122 | - |
dc.identifier.kciid | ART002809476 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85124585533 | - |
dc.citation.endPage | 122 | - |
dc.citation.startPage | 110 | - |
dc.citation.title | Korean Circulation Journal | - |
dc.citation.volume | 52 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Oh, Seyeon | - |
dc.contributor.affiliatedAuthor | Ahn, Kyung-Jin | - |
dc.contributor.affiliatedAuthor | Jang, Albert Youngwoo | - |
dc.contributor.affiliatedAuthor | Byun, Kyunghee | - |
dc.contributor.affiliatedAuthor | Chung, Wook-Jin | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | Stem cells | - |
dc.subject.keywordAuthor | Exosomes | - |
dc.subject.keywordAuthor | Pulmonary arterial hypertension | - |
dc.subject.keywordAuthor | Right heart failure | - |
dc.subject.keywordAuthor | N | - |
dc.subject.keywordPlus | MESENCHYMAL STROMAL CELLS | - |
dc.subject.keywordPlus | NITRIC-OXIDE SYNTHASE | - |
dc.subject.keywordPlus | ARTERIAL-HYPERTENSION | - |
dc.subject.keywordPlus | EXTRACELLULAR VESICLES | - |
dc.subject.keywordPlus | MOUSE MODEL | - |
dc.subject.keywordPlus | CAPACITY | - |
dc.subject.keywordPlus | HYPOXIA | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | DELIVERY | - |
dc.subject.keywordPlus | INDUCE | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.